Wolfgang Wick became the first German Chair of an independent Neurooncology department in 2007. In 2014, he became the Medical Director of the Neurology Clinic at MFHD. With his scientific record of accomplishment and function as chairman (2009-2015) of the EORTC Brain Tumor Group, as a member of the ECCO Board of Directors and president of EANO and NOA, Wolfgang Wick is one of the key figures in international neurooncology. The overarching goal of his research is to understand the biology of glioblastoma and to rapidly translate these insights into clinical application. Together with Frank Winkler and Varun Venkataramani he develops the topic of Cancer Neuroscience.
As part of his clinical trials activity, Wolfgang Wick develops and runs several early as well as multi-national academic and industry-sponsored trials and successfully develops molecular biomarkers for brain tumors.
Recently, he became scientific co-director (with Michael Boutros) of the Health + Life Science Alliance Heidelberg/Mannheim and is newly elected Chairman of the German Science and Humanities Council.